Rockwell Medical, Inc. (RMTI) Financials

RMTI Assets vs Liabilities

DateAssetsLiabilities
2023-09-30 52.6 million 31.1 million
2023-06-30 38.0 million 28.5 million
2023-03-31 40.5 million 27.9 million
2022-12-31 46.6 million 32.5 million

RMTI Free Cash Flow and Stock based compensation

Graph available only for supporters. Become a supporter to see it.
DateFree Cash FlowStock based compensation
2023-09-30 -3.8 million 212000
2023-06-30 -1.8 million 309000
2023-03-31 -4.0 million 193000
2022-12-31 -678000 220000

RMTI Net Income

No data available :(

RMTI Cash and Debt

Graph available only for supporters. Become a supporter to see it.
DateCashDebtCapital Lease
2023-09-30 11.7 million - 5.4 million
2023-06-30 9.0 million 4.7 million 5.9 million
2023-03-31 16.8 million 6.1 million 6.2 million
2022-12-31 21.5 million - 6.7 million

RMTI Shares Outstanding

Graph available only for supporters. Become a supporter to see it.
DateShares Outstanding
2023-09-30 27.5 million
2023-06-30 18.5 million
2023-03-31 18.4 million
2022-12-31 11.5 million

RMTI Expenses

Graph available only for supporters. Become a supporter to see it.
DateCapexR&DG&AS&M
2023-09-30 16000 494000 2.9 million 556000
2023-06-30 80000 167000 3.3 million 530000
2023-03-31 145000 278000 3.3 million 498000
2022-12-31 84000 156000 3.8 million 352000

RMTI Cost of Revenue

Graph available only for supporters. Become a supporter to see it.
DateRevenueCost of Revenue
2023-09-30 23.8 million 21.6 million
2023-06-30 18.1 million 17.0 million
2023-03-31 19.7 million 17.1 million
2022-12-31 19.3 million 17.0 million

RMTI

Price: $1.46

52 week price:
1.16
6.24

Earnings Per Share: -0.37 USD

P/E Ratio: -1.36

Exchange: NCM

Sector: Healthcare

Industry: Drug Manufacturers - Specialty & Generic

Volume: 309500

Ebitda: -4.9 million

Market Capitalization: 47.4 million

Links: